{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:20:05Z","timestamp":1793751605901,"version":"4.6.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.euroneuro.2024.03.006","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T09:08:00Z","timestamp":1713517680000},"page":"5-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Antidepressants compared to placebo for people with binge eating disorder: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3122-5542","authenticated-orcid":false,"given":"Angeliki L.","family":"Sioziou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7978-6496","authenticated-orcid":false,"given":"Andreas S.","family":"Lappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menelaos","family":"Skarlatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4797-8546","authenticated-orcid":false,"given":"Christina","family":"Mesiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Florou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2152-161X","authenticated-orcid":false,"given":"Aikaterini","family":"Argyrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6401-0828","authenticated-orcid":false,"given":"Nikos","family":"Christodoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9490-8356","authenticated-orcid":false,"given":"Michail","family":"Chourdakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6943-5091","authenticated-orcid":false,"given":"Myrto","family":"Samara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2024.03.006_bib0001","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev-clinpsy-081219-110907","article-title":"Cognitive Behavioral Therapy for the Eating Disorders","volume":"17","author":"Agras","year":"2021","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.euroneuro.2024.03.006_bib0002","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.physbeh.2014.04.032","article-title":"Eating attitudes of anorexia nervosa, bulimia nervosa, binge eating disorder and obesity without eating disorder female patients: differences and similarities","volume":"131","author":"Alvarenga","year":"2014","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.euroneuro.2024.03.006_bib0003","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-015-0445-6","article-title":"Binge-eating disorder diagnosis and treatment: a recap in front of DSM-5","volume":"15","author":"Amianto","year":"2015","journal-title":"BMC Psychiatry"},{"issue":"April","key":"10.1016\/j.euroneuro.2024.03.006_bib0004","article-title":"Pharmacotherapy compared to placebo for people with Bulimia Nervosa: a systematic review and meta-analysis","volume":"327","author":"Argyrou","year":"2023","journal-title":"Psychiatry Res."},{"issue":"11","key":"10.1016\/j.euroneuro.2024.03.006_bib0005","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.4088\/JCP.v63n1113","article-title":"A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder","volume":"63","author":"Arnold","year":"2002","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.euroneuro.2024.03.006_bib0006","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/erv.2930","article-title":"A comparison of the eating disorder service experiences of autistic and non-autistic women in the UK","volume":"30","author":"Babb","year":"2022","journal-title":"Eur. Eat. Disord. Rev."},{"issue":"1 30\u20131","key":"10.1016\/j.euroneuro.2024.03.006_bib0007","first-page":"0","article-title":"Naltrexone, an opioid blocker, alters taste perception and nutrient intake in humans","volume":"261","author":"Bertino","year":"1991","journal-title":"Am. J. Physiol. - Regul. Integr. Compar. Physiol."},{"issue":"6","key":"10.1016\/j.euroneuro.2024.03.006_bib0008","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/M15-2455","article-title":"Binge-eating disorder in adults: a systematic review and meta-analysis","volume":"165","author":"Brownley","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.euroneuro.2024.03.006_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2023.05.008","article-title":"Psychedelics in the treatment of eating disorders: rationale and potential mechanisms","volume":"75","author":"Calder","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2\u20133","key":"10.1016\/j.euroneuro.2024.03.006_bib0010","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.psychres.2012.04.037","article-title":"A prospective study of predictors of relapse in anorexia nervosa: implications for relapse prevention","volume":"200","author":"Carter","year":"2012","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.euroneuro.2024.03.006_bib0011","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/capr.12347","article-title":"Exploring harm in psychotherapy: perspectives of clinicians working with children and young people","volume":"20","author":"Castro Batic","year":"2020","journal-title":"Couns. PsychOther Res."},{"issue":"8","key":"10.1016\/j.euroneuro.2024.03.006_bib0012","doi-asserted-by":"crossref","first-page":"e968","DOI":"10.4088\/JCP.15m10059","article-title":"Estimating the prevalence of binge eating disorder in a community sample from the United States: comparing DSM-IV-TR and DSM-5 criteria","volume":"77","author":"Cossrow","year":"2016","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.03.006_bib0013","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1176\/appi.ajp.23180001","article-title":"The American psychiatric association practice guideline for the treatment of patients with eating disorders","volume":"180","author":"Crone","year":"2023","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.euroneuro.2024.03.006_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu10070829","article-title":"Obesity with comorbid eating disorders: associated health risks and treatment approaches","volume":"10","author":"da Luz","year":"2018","journal-title":"Nutrients"},{"issue":"December 2023","key":"10.1016\/j.euroneuro.2024.03.006_bib0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.euroneuro.2023.10.002","article-title":"The never-ending problem: sample size matters","volume":"79","author":"De Prisco","year":"2024","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.euroneuro.2024.03.006_bib0016","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/oby.2005.126","article-title":"Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder","volume":"13","author":"Devlin","year":"2005","journal-title":"Obes. Res."},{"issue":"7109","key":"10.1016\/j.euroneuro.2024.03.006_bib0017","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"SUPPL. 11","key":"10.1016\/j.euroneuro.2024.03.006_bib0018","first-page":"37","article-title":"Weight gain and antidepressants","volume":"61","author":"Fava","year":"2000","journal-title":"J. Clin. Psychiatry"},{"issue":"June","key":"10.1016\/j.euroneuro.2024.03.006_bib0019","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jad.2023.06.068","article-title":"Psychopharmacology of eating disorders: systematic review and meta-analysis of randomized controlled trials","volume":"338","author":"Fornaro","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.euroneuro.2024.03.006_bib0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00148581-200911030-00005","article-title":"Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents","volume":"11","author":"Garnock-Jones","year":"2009","journal-title":"Pediatr. Drugs"},{"issue":"6","key":"10.1016\/j.euroneuro.2024.03.006_bib0021","first-page":"2018","article-title":"Psychological, pharmacological, and combined treatments for binge eating disorder: a systematic review and metaanalysis","author":"Ghaderi","year":"2018","journal-title":"PeerJ."},{"issue":"6","key":"10.1016\/j.euroneuro.2024.03.006_bib0022","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1017\/S1092852915000668","article-title":"The role of the opioid system in binge eating disorder","volume":"20","author":"Giuliano","year":"2015","journal-title":"CNS Spectr."},{"key":"10.1016\/j.euroneuro.2024.03.006_bib0023","doi-asserted-by":"crossref","unstructured":"Grant, J.E., Valle, S., Cavic, E., Redden, S.A., & Samuel, R. (2019). A double-blind, placebo-controlled study of vortioxetine in the treatment of binge eating disorder. 52(7), 786\u2013794. https:\/\/doi.org\/10.1002\/eat.23078.A.","DOI":"10.1002\/eat.23078"},{"issue":"3","key":"10.1016\/j.euroneuro.2024.03.006_bib0024","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s13679-023-00517-0","article-title":"Binge-eating disorder interventions: review, current status, and implications","volume":"12","author":"Grilo","year":"2023","journal-title":"Curr. Obes. Rep."},{"issue":"1","key":"10.1016\/j.euroneuro.2024.03.006_bib0025","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.clinthera.2020.10.010","article-title":"Naltrexone + bupropion combination for the treatment of binge- eating disorder with obesity: a randomized, controlled pilot study","volume":"43","author":"Grilo","year":"2021","journal-title":"Clin. Ther."},{"issue":"12","key":"10.1016\/j.euroneuro.2024.03.006_bib0026","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1176\/appi.ajp.20220267","article-title":"Naltrexone-Bupropion and behavior therapy, alone and combined, for binge-eating disorder: randomized double-blind placebo-controlled trial","volume":"179","author":"Grilo","year":"2022","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.03.006_bib0027","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/oby.23898","article-title":"Naltrexone\/bupropion for binge-eating disorder: a randomized, double-blind, placebo-controlled trial","author":"Grilo","year":"2023","journal-title":"Obesity"},{"issue":"3","key":"10.1016\/j.euroneuro.2024.03.006_bib0028","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.biopsych.2004.11.002","article-title":"Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison","volume":"57","author":"Grilo","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2024.03.006_bib0029","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/eat.20599","article-title":"DSM-IV psychiatric disorder comorbidity and its correlates in binge eating disorder","volume":"42","author":"Grilo","year":"2009","journal-title":"Int. J. Eat. Disord."},{"issue":"2","key":"10.1016\/j.euroneuro.2024.03.006_bib0030","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/eat.20946","article-title":"Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial","volume":"45","author":"Guerdjikova","year":"2012","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.euroneuro.2024.03.006_bib0031","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2147\/NDT.S80881","article-title":"Novel pharmacologic treatment in acute binge eating disorder\u2013 Role of lisdexamfetamine","volume":"12","author":"Guerdjikova","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"2","key":"10.1016\/j.euroneuro.2024.03.006_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hup.899","article-title":"High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial","volume":"23","author":"Guerdjikova","year":"2008","journal-title":"Hum. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2024.03.006_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40337-015-0056-0","article-title":"Prevalence and sociodemographic correlates of DSM-5 eating disorders in the Australian population","volume":"3","author":"Hay","year":"2015","journal-title":"J. Eat. Disord."},{"issue":"1","key":"10.1016\/j.euroneuro.2024.03.006_bib0034","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/capr.12407","article-title":"What metrics of harm are being captured in clinical trials involving talking treatments for young people? A systematic review of registered studies on the ISRCTN","volume":"22","author":"Hayes","year":"2022","journal-title":"Couns. PsychOther Res."},{"issue":"7","key":"10.1016\/j.euroneuro.2024.03.006_bib0035","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00004583-199907000-00012","article-title":"Recovery and relapse in anorexia and bulimia nervosa: a 7.5-year follow- up study","volume":"38","author":"Herzog","year":"1999","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"7829","key":"10.1016\/j.euroneuro.2024.03.006_bib0036","first-page":"1","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ (Online)"},{"key":"10.1016\/j.euroneuro.2024.03.006_bib0037","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/9781119536604.ch8","article-title":"Assessing risk of bias in a randomized trial","author":"Higgins","year":"2019","journal-title":"Cochrane Handb. Syst. Rev. Intervent."},{"key":"10.1016\/j.euroneuro.2024.03.006_bib0038","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.03.006_bib0039","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1037\/ccp0000358","article-title":"Meta-analysis of the efficacy of psychological and medical treatments for binge-eating disorder","volume":"87","author":"Hilbert","year":"2019","journal-title":"J. Consult. Clin. Psychol."},{"issue":"2","key":"10.1016\/j.euroneuro.2024.03.006_bib0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40261-015-0358-7","article-title":"Pharmacokinetics and exposure-response relationships of dasotraline in the treatment of attention-deficit\/hyperactivity disorder in adults","volume":"36","author":"Hopkins","year":"2016","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.euroneuro.2024.03.006_bib0041","unstructured":"Horne, R.L., D, I., Pope, D.H.C., Hudson, J., Lineberry, C.C., Ph, D., Cato, A., & Ph, D. (1988). Treatment of Bulimia \\Vith Bupropion: a Multicenter Controlled Trial. July."},{"issue":"12","key":"10.1016\/j.euroneuro.2024.03.006_bib0042","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1176\/ajp.155.12.1756","article-title":"Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial","volume":"155","author":"Hudson","year":"1998","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.euroneuro.2024.03.006_bib0043","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/erv.2244","article-title":"Autism spectrum disorders in eating disorder populations: a systematic review","volume":"21","author":"Huke","year":"2013","journal-title":"Eur. Eat. Disord. Rev."},{"issue":"3","key":"10.1016\/j.euroneuro.2024.03.006_bib0044","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/eat.22670","article-title":"Addressing critical gaps in the treatment of eating disorders","volume":"50","author":"Kazdin","year":"2017","journal-title":"Int. J. Eat. Disord."},{"issue":"12","key":"10.1016\/j.euroneuro.2024.03.006_bib0045","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1176\/appi.ajp.162.12.2263","article-title":"Postremission predictors of relapse in women with eating disorders","volume":"162","author":"Keel","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2024.03.006_bib0046","doi-asserted-by":"crossref","first-page":"409","DOI":"10.31887\/DCNS.2008.10.4\/kkelly","article-title":"Toward achieving optimal response: understanding and managing antidepressant side effects","volume":"10","author":"Kelly","year":"2008","journal-title":"Dialog. Clin. Neurosci."},{"issue":"9","key":"10.1016\/j.euroneuro.2024.03.006_bib0047","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.biopsych.2012.11.020","article-title":"The prevalence and correlates of binge eating disorder in the WHO World Mental Health Surveys","volume":"73","author":"Kessler","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2024.03.006_bib0048","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4088\/JCP.v59n0403","article-title":"Opioid antagonists in the treatment of impulse-control disorders","volume":"59","author":"Kim","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2024.03.006_bib0049","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1098-108X(199911)26:3<231::AID-EAT1>3.0.CO;2-6","article-title":"Imipramine and diet counseling with psychological support in the treatment of obese binge eaters: a randomized, placebo-controlled double- blind study","volume":"26","author":"Laederach-Hofmann","year":"1999","journal-title":"Int. J. Eat. Disord."},{"issue":"1","key":"10.1016\/j.euroneuro.2024.03.006_bib0050","first-page":"53","article-title":"Psychological Treatments that Cause Harm","volume":"2","author":"Lilienfeld","year":"2007","journal-title":"Psychol. Sci."},{"key":"10.1016\/j.euroneuro.2024.03.006_bib0051","first-page":"1","article-title":"Perspectives on barriers to treatment engagement of people with eating disorder symptoms who have not undergone treatment : a qualitative study","author":"Liu","year":"2022","journal-title":"BMC Psychiatry"},{"issue":"6","key":"10.1016\/j.euroneuro.2024.03.006_bib0052","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0361-9230(85)90115-7","article-title":"Naltrexone and human eating behavior: a dose-ranging inpatient trial in moderately obese men","volume":"14","author":"Maggio","year":"1985","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.euroneuro.2024.03.006_bib0053","doi-asserted-by":"crossref","unstructured":"McElroy, S.L. ., Hudson, J.I. ., Shishuka, M., Welge, J.A.., Nelson, E.B.., & Keck, P.E.. (2003). Citalopram in the treatment of binge eating disorder.","DOI":"10.4088\/JCP.v64n0711"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.03.006_bib0054","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1176\/appi.ajp.157.6.1004","article-title":"Placebo-controlled trial of sertraline in the treatment of binge eating disorder","volume":"157","author":"McElroy, Susan L","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.03.006_bib0055","first-page":"89","article-title":"Treatment of binge eating disorder with sertraline: a randomized controlled trial","volume":"16","author":"Milano","year":"2005","journal-title":"Biomed. Res."},{"issue":"3","key":"10.1016\/j.euroneuro.2024.03.006_bib0056","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1037\/1064-1297.10.3.213","article-title":"Clinical uses of naltrexone: a review of the evidence","volume":"10","author":"Modesto-Lowe","year":"2002","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"August","key":"10.1016\/j.euroneuro.2024.03.006_bib0057","article-title":"Treatment of eating disorders: a systematic meta-review of meta-analyses and network meta-analyses","volume":"142","author":"Monteleone","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.euroneuro.2024.03.006_bib0058","doi-asserted-by":"crossref","DOI":"10.1007\/BF03327645","article-title":"Drop-out rate in eating disorders: could it be a function of patienttherapist relationship?","volume":"12","author":"Morlino","year":"2007","journal-title":"Eat. Weight Disord."},{"issue":"4","key":"10.1016\/j.euroneuro.2024.03.006_bib0059","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/1098-108X(199505)17:4<395::AID-EAT2260170412>3.0.CO;2-I","article-title":"Onset of binge eating, dieting, obesity, and mood disorders among subjects seeking treatment for binge eating disorder","volume":"17","author":"Mussell","year":"1995","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.euroneuro.2024.03.006_bib0060","doi-asserted-by":"crossref","DOI":"10.1177\/1179573517728090","article-title":"Review of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder","volume":"9","author":"Najib","year":"2017","journal-title":"J. Cent. Nerv. Syst. Dis."},{"issue":"12","key":"10.1016\/j.euroneuro.2024.03.006_bib0061","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/eat.22643","article-title":"The risk of eating disorders comorbid with attention-deficit\/hyperactivity disorder: a systematic review and meta-analysis","volume":"49","author":"Nazar","year":"2016","journal-title":"Int. J. Eat. Disord."},{"issue":"7","key":"10.1016\/j.euroneuro.2024.03.006_bib0062","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1177\/1087054712455503","article-title":"ADHD rate in obese women with binge eating and bulimic behaviors from a weight-loss clinic","volume":"20","author":"Nazar","year":"2016","journal-title":"J. Atten. Disord."},{"issue":"3","key":"10.1016\/j.euroneuro.2024.03.006_bib0063","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/eat.22380","article-title":"Predictors of rapid relapse in bulimia nervosa","volume":"48","author":"Olmsted","year":"2015","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.euroneuro.2024.03.006_bib0064","doi-asserted-by":"crossref","unstructured":"Parry, G.D., Crawford, M.J., & Duggan, C. (2016). Iatrogenic harm from psychological therapies \u2013 time to move on {. 210\u2013212. https:\/\/doi.org\/10.1192\/bjp.bp.115.163618.","DOI":"10.1192\/bjp.bp.115.163618"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.03.006_bib0065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00737-003-0172-8","article-title":"A double-blind, placebo-controlled trial of fluvoxamine in binge eating disorder: a high placebo response","volume":"6","author":"Pearlstein","year":"2003","journal-title":"Arch. Women's Mental Health"},{"issue":"5","key":"10.1016\/j.euroneuro.2024.03.006_bib0066","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/erv.2517","article-title":"Comparative effectiveness of treatments for binge-eating disorder: systematic review and network meta-analysis","volume":"25","author":"Peat","year":"2017","journal-title":"Eur. Eat. Disord. Rev."},{"issue":"9","key":"10.1016\/j.euroneuro.2024.03.006_bib0067","doi-asserted-by":"crossref","DOI":"10.1038\/oby.2008.333","article-title":"Review and meta-analysis of pharmacotherapy for binge-eating disorder","volume":"16","author":"Reas","year":"2008","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"10.1016\/j.euroneuro.2024.03.006_bib0068","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.appet.2010.09.019","article-title":"Comparison of individual and group cognitive behavioral therapy for binge eating disorder. A randomized, three-year follow-up study","volume":"55","author":"Ricca","year":"2010","journal-title":"Appetite"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.03.006_bib0069","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40337-023-00833-9","article-title":"Pharmacotherapy, alternative and adjunctive therapies for eating disorders: findings from a rapid review","volume":"11","author":"Rodan","year":"2023","journal-title":"J. Eat. Disord."},{"issue":"2","key":"10.1016\/j.euroneuro.2024.03.006_bib0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/eat.10080","article-title":"Predictors of relapse following successful dialectical behavior therapy for binge eating disorder","volume":"32","author":"Safer","year":"2002","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.euroneuro.2024.03.006_bib0071","doi-asserted-by":"crossref","DOI":"10.1007\/s41347-023-00345-y","article-title":"Remote vs face-to-face interventions for bulimia nervosa and binge-eating disorder: a systematic review and meta-analysis","author":"Samara","year":"2023","journal-title":"J. Technol. Behav. Sci."},{"key":"10.1016\/j.euroneuro.2024.03.006_bib0072","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.euroneuro.2021.08.001","article-title":"Lisdexamfetamine and binge-eating disorder: a systematic review and meta-analysis of the preclinical and clinical data with a focus on mechanism of drug action in treating the disorder","volume":"53","author":"Schneider","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.03.006_bib0073","doi-asserted-by":"crossref","unstructured":"Sch\u00fcnemann, H., Oxman, A., Vist, G., Higgins, J., Deeks, J., & Glasziou, P. (2008). Chapter 12: interpreting results and drawing conclusions. In: Higgins JPT, Green S, editors(s).","DOI":"10.1002\/9780470712184.ch12"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.03.006_bib0074","first-page":"189","article-title":"Atomoxetine A Review of its Use in Adults with Attention Deficit Hyperactivity Disorder","volume":"64","author":"Simpson","year":"2021","journal-title":"Adis. Drug Eval."},{"key":"10.1016\/j.euroneuro.2024.03.006_bib0075","unstructured":"Tell, R.A., Rosenthal, R., & Ph, D. (2008). Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy."},{"issue":"5","key":"10.1016\/j.euroneuro.2024.03.006_bib0076","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00737-016-0618-4","article-title":"Barriers to access and utilization of eating disorder treatment among women","volume":"19","author":"Thompson","year":"2016","journal-title":"Arch. Women's Mental Health"},{"issue":"10227","key":"10.1016\/j.euroneuro.2024.03.006_bib0077","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(20)30059-3","article-title":"Eating disorders","volume":"395","author":"Treasure","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.03.006_bib0078","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0195-6663(83)80045-2","article-title":"Naloxone reduces the food intake of normal human volunteers","volume":"4","author":"Trenchard","year":"1983","journal-title":"Appetite"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.03.006_bib0079","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/eat.23004","article-title":"Psychiatric and medical correlates of DSM-5 eating disorders in a nationally representative sample of adults in the United States","volume":"52","author":"Udo","year":"2019","journal-title":"Int. J. Eat. Disord."},{"issue":"2","key":"10.1016\/j.euroneuro.2024.03.006_bib0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.14740\/jocmr4066","article-title":"The opioid system and food intake: use of opiate antagonists in treatment of binge eating disorder and abnormal eating behavior","volume":"12","author":"Valbrun","year":"2020","journal-title":"J. Clin. Med. Res."},{"issue":"3","key":"10.1016\/j.euroneuro.2024.03.006_bib0081","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/eat.20696","article-title":"Meta-analysis of the effectiveness of psychological and pharmacological treatments for binge eating disorder","volume":"43","author":"Vocks","year":"2010","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.euroneuro.2024.03.006_bib0082","doi-asserted-by":"crossref","unstructured":"White, M.A. ., & Grilo, C.M. (2013). Bupropion for overweight women with Binge Eating Disorder-Randomized Double-blind Placebo controlled trial (pp. 400\u2013406).","DOI":"10.4088\/JCP.12m08071"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.03.006_bib0083","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/1087054719864644","article-title":"Efficacy and safety of dasotraline in children with ADHD: a laboratory classroom study","volume":"24","author":"Wigal","year":"2020","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.euroneuro.2024.03.006_bib0084","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.2147\/NDT.S107777","article-title":"Characteristics of binge eating disorder in relation to diagnostic criteria","volume":"12","author":"Wilfley","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/j.euroneuro.2024.03.006_bib0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/COPD.S1121","article-title":"The use of bupropion SR in cigarette smoking cessation","volume":"3","author":"Wilkes","year":"2008","journal-title":"Int. J. COPD"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.03.006_bib0086","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0031-9384(96)80017-5","article-title":"Selective effects of naltrexone on food pleasantness and intake","volume":"60","author":"Yeomans","year":"1996","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.euroneuro.2024.03.006_bib0087","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0031-9384(97)00101-7","article-title":"Effects of naltrexone on food intake and changes in subjective appetite during eating: evidence for opioid involvement in the appetizer effect","volume":"62","author":"Yeomans","year":"1997","journal-title":"Physiol. Behav."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X24000646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X24000646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T11:20:49Z","timestamp":1719832849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X24000646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":87,"alternative-id":["S0924977X24000646"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2024.03.006","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressants compared to placebo for people with binge eating disorder: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2024.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}